Reply to: Costa DC et al. The use of subconjunctival triamcinolone acetonide (SCTA) in the management of corneal endothelial graft rejection.

Reply to: Costa DC et al. The use of subconjunctival triamcinolone acetonide (SCTA) in the management of corneal endothelial graft rejection.